Agomelatine as a Novel Treatment Option in Panic Disorder, Results From an 8-Week Open-Label Trial

Lippincott, Williams & Wilkins, Journal of Clinical Psychopharmacology, 3(35), p. 336-338, 2015

Journal article published in 2015 by Klaas M. Huijbregts, Neeltje M. Batelaan

, Judy Schonenberg, Gerthe Veen, Anton J. van Balkom

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by